Seeyond Reduces Position in CME Group Inc. (NASDAQ:CME)

Seeyond decreased its holdings in CME Group Inc. (NASDAQ:CME) by 0.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,226 shares of the financial services provider’s stock after selling 49 shares during the quarter. Seeyond’s holdings in CME Group were worth $1,962,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also made changes to their positions in CME. Solstein Capital LLC purchased a new stake in CME Group in the first quarter worth $28,000. Capital Analysts LLC lifted its stake in CME Group by 370.0% in the first quarter. Capital Analysts LLC now owns 188 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 148 shares during the period. RE Advisers Corp bought a new position in CME Group in the second quarter worth $38,000. Glassman Wealth Services raised its holdings in CME Group by 54.0% in the second quarter. Glassman Wealth Services now owns 191 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 67 shares in the last quarter. Finally, Eagle Bay Advisors LLC bought a new position in CME Group in the second quarter worth $52,000. 86.19% of the stock is owned by institutional investors.

A number of equities analysts have issued reports on CME shares. Berenberg Bank reiterated a “hold” rating on shares of CME Group in a report on Wednesday, September 15th. Piper Sandler reiterated a “buy” rating and issued a $230.00 price objective on shares of CME Group in a report on Friday, October 1st. Morgan Stanley decreased their price objective on CME Group from $229.00 to $217.00 and set an “equal weight” rating for the company in a report on Friday, October 8th. TheStreet downgraded CME Group from a “b” rating to a “c+” rating in a report on Wednesday, August 18th. Finally, Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price target for the company in a report on Tuesday, September 14th. One analyst has rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $211.38.

NASDAQ:CME traded up $1.35 on Thursday, hitting $205.61. The stock had a trading volume of 11,155 shares, compared to its average volume of 1,438,494. The stock has a market cap of $73.84 billion, a price-to-earnings ratio of 38.18 and a beta of 0.43. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business’s 50-day simple moving average is $198.24 and its two-hundred day simple moving average is $206.47. CME Group Inc. has a 52-week low of $146.89 and a 52-week high of $221.82.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.59 by $0.05. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.17 billion. CME Group had a return on equity of 8.33% and a net margin of 41.64%. As a group, equities research analysts anticipate that CME Group Inc. will post 6.65 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 27th. Stockholders of record on Friday, September 10th were given a dividend of $0.90 per share. The ex-dividend date of this dividend was Thursday, September 9th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.75%. CME Group’s payout ratio is currently 53.57%.

In related news, insider Sean Tully sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total value of $1,001,000.00. Following the transaction, the insider now directly owns 23,479 shares of the company’s stock, valued at approximately $4,700,495.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Martin J. Gepsman sold 1,000 shares of CME Group stock in a transaction that occurred on Monday, August 30th. The stock was sold at an average price of $201.00, for a total value of $201,000.00. Following the completion of the sale, the director now directly owns 27,368 shares in the company, valued at approximately $5,500,968. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 9,000 shares of company stock worth $1,786,150. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Featured Story: How do candlesticks reflect price movement?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.